96421 ⎘
Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof sharing nitrogen; Heterocyclic radicals containing only nitrogen atoms as ring hetero atom Imidazole radicals
VIRAL INHIBITORS, THE SYNTHESIS THEROF, AND INTERMEDIATES THERETO
#2VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
#3VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
#4VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
#5VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
#6MODIFIED NUCLEOTIDE REAGENTS
#7CRYSTALLINE PHASES OF 5,6-DICHLORO-2-(ISOPROPYLAMINO)-(1 BETA-L-RIBOFURANOSYL)1H-BENZIMIDAZOLE
#8FLEX-NUCLEOSIDE ANALOGUES, NOVEL THERAPEUTICS AGAINST VIRUSES
#9Glycosylation method involving trivalent iodine reagent
#10Viral inhibitors, the synthesis thereof, and intermediates thereto
#11VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
#12Viral inhibitors, the synthesis thereof, and intermediates thereto
#13VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
#14NOVEL GALACTOSIDE INHIBITOR OF GALECTINS
#15Modified nucleotide reagents
#16MODIFIED DNA-ENCODED CHEMICAL LIBRARY AND METHODS RELATED THERETO
#17Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 β-L-ribofuranosyl)-1H-benzimidazole
#18NOVEL GALACTOSIDE INHIBITOR OF GALECTINS
#19Broad-spectrum antiviral nucleoside derivatives
#20ADENOSINE ANALOG AND ITS USE IN REGULATING THE CIRCADIAN CLOCK
#21AMP-activated protein kinase activating compounds and uses thereof
#22Small molecule inhibitors of Galectin-3
#23NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY
#24Modified nucleotide reagents
#25Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1-beta-L-ribofuranosyl)-1H-benzimidazole
#26TREATING OCULAR NEOVASCULARIZATION
#27SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
#28NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY
#29NOVEL CRYSTALLINE FORMS OF AN ANTIVIRAL BENZIMIDAZOLE COMPOUND
#30Modified nucleotide reagents
#31Compositions and methods for treating viral infections
#32Metal oxide catalyzed radiofluorination
#33Purine derivatives as CD73 inhibitors for the treatment of cancer
#34Treating ocular neovascularization
#35NOVEL CRYSTALLINE FORMS OF AN ANTIVIRAL BENZIMIDAZOLE COMPOUND
#36CRYSTALLINE PHASES OF 5,6-DICHLORO-2-(ISOPROPYLAMINO)-(1-BETA-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE
#37Compositions and methods for treating viral infections
#38Non-medical increase or maintenance of body weight of a mammal
#39Method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK)
#40Purine nucleoside analogues for treating flaviviridae including hepatitis C
#41CRYSTALLINE PHASES OF 5,6-DICHLORO-2-(ISOPROPYLAMINO)-(1-ß-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE
#42Novel Crystalline Forms Of An Antiviral Benzimidazole Compound
#43Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositions
#44Compounds useful in imaging and therapy
#45Nucleosides with antiviral and anticancer activity
#46Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole
#47Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
#48Stereoselective synthesis of phosphorus containing actives
#49Compositions and methods for treating viral infections
#50Crystalline forms of an antiviral benzimidazole compound
#51Amidite for synthesizing modified nucleic acid and method for synthesizing modified nucleic acid
#52Combinatorial production of nucleotide and nucleoside (XiTP) analogues
#53Novel Crystalline Forms Of An Antiviral Benzimidazole Compound
#54Nucleosides with antiviral and anticancer activity
#55NOVEL VIRAL REPLICATION INHIBITORS
#56Process for preparing substituted benzimidazole compounds
#57Purine nucleoside analogues for treating including hepatitis C
#58Amidite for synthesizing modified nucleic acid and method for synthesizing modified nucleic acid
#59Detectable labeled nucleoside analogs and methods of use thereof
#60Process for preparing substituted benzimidazole compounds
#61METHODS, COMPOSITIONS, AND FORMULATIONS FOR PREVENTING OR REDUCING ADVERSE EFFECTS IN A PATIENT
#62Imidazopyridine derivatives
#63Crystalline forms of an antiviral benzimidazole compound
#64Benzimidazole derivatives and medical uses thereof
#65Detectable labeled nucleoside analogs and methods of use thereof
#66Detectable labeled nucleoside analogs and methods of use thereof
#67Ring-expanded nucleosides and nucleotides
#68Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases
#69Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases
#70Process for preparing substituted benzimidazole compounds
#71Nucleic acid analysis techniques
#72Nucleic acid labeling compounds
#73Nucleic acid analysis techniques
#74Purine nucleoside analogues for treating Flaviviridae including hepatitis C